Kantar Health Catalysts
Kantar Health helps life sciences companies
accelerate their clinical, commercial, and
brand decisions and improve their
contribution to patient health.
Market Access Spotlight
In order to achieve timely market access,
Kantar Health recommends clients
“begin with the end in mind” in early
development by identifying unmet need
and value drivers.
Kantar Health's oncology specialists hold
Key Opinion Leader status with leading life
sciences companies, providing insights at
every stage of the product lifecycle.
Emerging Markets Spotlight
Kantar Health leverages its global reach
with local teams in emerging markets to
deliver key insights for launching products
in these regions.
Real-World Research & Value
Kantar Health provides the strategies and
scientific evidence to help clients differentiate
products, demonstrate value and mitigate
risks across the product lifecycle.
Most recent news
Catherine Alberny Appointed as Regional Talent Director of Southern Europe & France, and Global Accounts for Kantar Health (Wpp Group)
Kantar Health Uncovers Opportunities and Challenges for Biosimilars in Asia
Patients Experience Impairments Just One Year after Knee Replacement Surgery
Kantar Health to Highlight Role of Patient-Reported Outcomes in Russia
Latest blog posts
PI3K Inhibition in CLL Wows at ASH! Pivotal data for Idelalisib plus Rituxan
New CD20 MAbs on the CLL block: Can Arzerra stand up to Gazyva?
Slow and Steady Advances in Treatment of Newly-Diagnosed Multiple Myeloma
Non-Small Cell Lung Cancer – a global view on standards of care and patient outcomes.
Download white papers, case studies, publications & citations completely free of charge.
Visit us at a conference or attend our seminars and workshops.